Tuesday, October 27, 2026

EQT Q3 FY12/26 Earnings Review - Distribute Rating

EQT moved to Distribute at $56.29 after Q3 revenue fell 9.6%; a 44% trailing free-cash-flow margin signals cycle risk despite lower debt and an EPS beat.

EQT $33B

Cestrian Capital Research Oct 27 2 clicks

Oct 27 GFL $20B

My Last GFL Update - Hopefully

310 Value’s Newsletter 5 clicks

Oct 27 LITE $62B

Expert Call | Lumentum Optical Chip Capacity, EML/SiPh Outlook & Industry Pricing

P Equity Research 2 clicks

From X

@ACapitalLP Sep 17

A Capital on X

The fun has just begun… $COO https://t.co/OMPI29HbQG

@ACapitalLP Sep 17 2 clicks

A Capital on X

Do you see it? $COO https://t.co/qydMW4xaH9

@DeepSailCapital Sep 17 2 clicks

Deep Sail Capital on X

@jiahanjimliu @JKeynesAlpha @PSInvestor Valuation seems a bit stretched here. I get the thesis, it’s just things don’t go straight up forever. Someone is going to cut $TEM at the knees soon.

@blondesnmoney Sep 17 1 click

Cluseau Investments on X

Disclaimer: I have sold this position and have no view on the valuation or future prospects My craziest OTC adventure this year was discovering a single-asset refinery that sells Jet Fuel to the US Military. It sounds kinda crazy, but it's the exact type of ridiculous setup funny enough to look into. In July, refining crack spreads were blowing out, and nearly every refiner $PBF, $PARR, $VLO, $PSX were steamrolling. I wanted some exposure, but I felt sheepish chasing names that were already tearing it up. I started looking at smaller refiners, but nearly everyone was in the 3x - 5x forward earnings range, not expensive, but for a cyclical, also not really that cheap. It turns out that, aside from the megacap refiners and $PARR, there's only one other US listed microcap refiner, Blue Dolphin Energy $BDCO. The stock is heavily insider owned, and at the time, was trading at just over 4x Q1 earnings ($0.99). Crack spreads are publicly viewable, and other refiners were demolishing estimates - $PARR came in at $11 in Q2, triple Q1, so it didn't take too much math to realize BDCO's Q2 was gonna be strong given jet fuel prices, and that the stock was potentially trading under 1x forward earnings. Of course, it's an OTC name with limited liquidity so you can't realize size it up, but how often do you get a chance to buy someone who supplies jet fuel to the Department of Defense under 1x annualized earnings? It was almost comedic, the story was funny enough to swallow the OTC stigma and just pick up a little bit up. About a week later, Q2 results came in at $1.19 (putting 1H earnings at ($2.18), and the market suddenly realized a stock trading at $4 on $2.18 of two quarter's EPS was just too cheap. The stock hit $18 today - I've been trimming since entry and am finally out. It was a tiny position, but I continue to find it ridiculous that these OTC setups exist. With a small amount of capital and a love for reading filings, you can probably find a slew of OTC names that are actually decently profitable that are simply too small for larger investors to take a stab at. I have no position in BDCO and have no opinion on it, $4 and $18 are totally different prices, but the fact this setup existed and somehow flew under the radar until earnings is pretty entertaining.

@BlueDuckCap Sep 17 1 click

BDC on X

@Jason @evanspiegel "After Elon Musk acquired Twitter in 2022 and re-organized the management and governance structure, Calacanis helped transition Twitter along with David Sacks.[25]" Jason - time to help transition $SNAP/Specs. Run the same playbook.

@BlueDuckCap Sep 17

BDC on X

@Jason @evanspiegel The progress is impressive. But mass market adoption remains years away. They need a size minority equity investor. If they get it, $snap goes up 50%.

@AsifSuria Sep 17

Asif Suria on X

Wrote about the Medtronic - MiniMed $MMED $MDT split-off for our mid-month update yesterday: https://t.co/V0EGS81yam

@AsifSuria Sep 17

Asif Suria on X

@MrMojoRisinX @ArbSensei @Msp194 Also worth visiting what happened with Johnson & Johnson/Kenvue a little over three years ago. $JNJ $KVUE Proration in that case was 23.23%

Novartis (NYSE: NVS) Stock Rating: Do Nothing After Q3 FY12/26 Earnings

Novartis grew Q3 sales 4% to $14.5bn and raised profit guidance, but pipeline failures triggered a $1.9bn impairment as net debt reached…

NVS $304B

Cestrian Capital Research Oct 27 3 clicks

AppFolio 3Q26 Business Recap: AI Agents Support Growth

AppFolio grew third-quarter revenue 19% as Realm-X AI agents gained adoption, lifting guidance to $1.122 billion to $1.127 billion.

APPF $7.6B

Speedwell Research Oct 27 5 clicks

Boeing (NYSE: BA) Stock Rating: Do Nothing After Q3 FY12/26 Earnings

Boeing posted $24.2 billion in Q3 revenue and $1.5 billion in operating cash flow, but commercial aircraft lost $697 million as production…

BA $136B

Cestrian Capital Research Oct 27 1 click

TTM Technologies: The Market Already Caught On To Peak Numbers

TTM Technologies’ record Q3 and data-center exposure drove a 27.7% stock drop as investors questioned debt-funded growth, leverage and the…

TTMI $7.7B

Nicolas Bolsinger Oct 27 1 click

Are Neoclouds Dead?

Neoclouds face tighter debt financing as AI infrastructure capex outruns cash flow, leaving cash-burning GPU providers more exposed than…

NBIS $42B

Daniel Romero Oct 27 9 clicks

Reddit: Deep Dive Analysis

Reddit generated $805 million in Q2 2026 revenue, 95% from ads, but slowing Google search referrals expose AI-driven traffic and…

RDDT $18B

Hated Moats Oct 27 6 clicks

Qualcomm Inc. (QCOM)

Qualcomm supplies chips for on-device AI agents and data center inference, with Meta and AWS agreements expanding its role across both…

QCOM $177B

SixSigmaCapital: Navigating the Financial Markets Oct 27 5 clicks

Single Stock Spotlight #17: Gamestop (GME)

GameStop’s $6.1 billion in net cash equivalents and shift toward collectibles underpin a $30 to $40 per-share valuation thesis.

GME $13B

Hidden Rock Capital's Newsletter Oct 27 4 clicks

Monte Investments Market Brief Vol. CXXXIII

Monte Investments updates Carpenter Technology after a 25% sell-off, tracks EQT’s $12.83 billion Range Resources acquisition and assesses…

CRS $15BKRMN $5.2B

Monte Independent Investment Research Oct 27 1 click

Merger Monday & Election Implications

EQT’s $50 billion merger with Range Resources and Ovintiv’s $1.26 billion acquisition of Logan Energy reshape North American oil and gas…

EQT $33BRRC $13B

Bison Insights Oct 26 7 clicks

Cadence Design Systems Q3 FY12/26 Earnings Review

Cadence Design Systems grew Q3 revenue 22% to $1.633 billion, built an $8.2 billion backlog and raised its 2026 revenue growth outlook to…

CDNS $89B

Cestrian Capital Research Oct 27 3 clicks

WULF · long

Terawulf INC

TeraWulf is shifting from bitcoin mining toward data centers, seeking a higher-quality and more defensive business model.

WULF $5.4B

Value Investors Club Jul 29

The Data Center Bridge

Small- and mid-cap data center stocks trade as one despite sharply different funding bridges: 12 of 15 cover fixed costs on signed…

IREN $9.9B

CV's Substack Oct 26 16 clicks

Celestica surges as the AI chip race keeps going

Celestica rose 12% after beating revenue and profit expectations and raising its full-year outlook, as AI chip demand supports contract…

CLS $33B

The Technology Letter Oct 26 1 click

Seagate sells off but the outlook is still very good

Seagate shares fell 8% after earnings offered less upside than prior quarters, but the hard-disk drive maker forecast another strong…

STX $139B

The Technology Letter Oct 26 1 click

Amkor Q3 FY12/26 Earnings Review

Amkor's Q3 sales were flat at $1.991 billion as computing and automotive/industrial growth offset a 27% communications decline; Q4 sales…

AMKR $10B

Cestrian Capital Research Oct 26 4 clicks

Quick Value #335 - Truist Financial (TFC)

Truist Financial trades at 10.5x earnings and 1.5x tangible book as new CEO Mike Lyons sells non-core assets and targets 16% to 18% ROTCE.

TFC $59B

Value Don't Lie Oct 26 5 clicks

Intuitive Surgical: The Long Road to Everyday Surgery

Intuitive Surgical built da Vinci into a 12,000-system surgical-robotics network performing 10,000 daily procedures, while high-volume…

ISRG $150B

MBI Deep Dives Oct 26 8 clicks

Molina & Kinsale

Molina Healthcare and Kinsale Capital’s earnings are reassessed through a long-term lens, emphasizing conviction and detachment during…

MOH $11BKNSL $8.8B

Bearstone Oct 26 8 clicks

Duolingo: The 2027 Bull Case Is Hidden In The Monetization Switch

Duolingo sacrificed over $50 million of 2026 bookings to reduce free-app friction, reaccelerate daily users and target 100 million DAUs by…

DUOL $7.6B

Geneva Investor Oct 26 4 clicks

Tuesday, October 27, 2026

A Capital on X

A Capital on X

Deep Sail Capital on X

Cluseau Investments on X

BDC on X

BDC on X

Asif Suria on X

Asif Suria on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 72 of 272

X accounts we follow

Investor letters we follow

Sectors